Older adults had a lower risk of dying from the flu when they took  oseltamivir (Tamiflu) during influenza hospitalizations, regardless of whether or not they were vaccinated against the virus, a new ...

A Canadian study published today in Open Forum Infectious Diseases shows that adults 65 years and older had a significant ...

Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

A network meta-analysis of 73 trials comparing the effectiveness of flu antivirals suggests that only baloxavir (Xofluza) may be better than standard care or a placebo in reducing the risk of ...

Oseltamivir is a novel influenza treatment that has been extensively investigated. We describe a series of retrospective analyses investigating various measures of clinical efficacy across ...

Also of note, oseltamivir (Tamiflu) had little or no effect on risk for hospital admission in high-risk patients (RD -0.4%, 95% CI -1.0 to 0.4; high certainty), and all the other antivirals ...

Antiviral medications such as neuraminidase inhibitors, like oseltamivir (Tamiflu) and zanamivir (Relenza), and endonuclease inhibitors, such as baloxavir (Xofluza), are used to alleviate symptoms ...